Device
NeoVas BCS
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph phase_1
1
33%
Ph not_applicable
2
67%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Other(3)
Detailed Status
unknown3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 1
Trials by Phase
Phase 11 (33.3%)
N/A2 (66.7%)
Trials by Status
unknown3100%
Recent Activity
Clinical Trials (3)
Showing 3 of 3 trials
NCT02305472Not Applicable
NeoVas Bioresorbable Coronary Scaffold Registry Study
NCT02305485Not Applicable
NeoVas Bioresorbable Coronary Scaffold Randomized Controlled Trial
NCT02195414Phase 1
NeoVas Bioresorbable Coronary Scaffold First-in-Man Study
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3